PAGE 1
WES MOORE, Governor Ch. 847

Chapter 847

(House Bill 932)

AN ACT concerning

Health Insurance – Utilization Review – Revisions

FOR the purpose of altering and establishing requirements and prohibitions related to
health insurance utilization review; altering requirements related to internal
grievance procedures and adverse decision procedures; altering certain reporting
requirements on health insurance carriers relating to adverse decisions; establishing
requirements on health insurance carriers and health care providers relating to the
provision of patient benefit information; and generally relating to health insurance
and utilization review.

BY adding to
Article – Health – General
Section 19–108.5
Annotated Code of Maryland
(2023 Replacement Volume)

BY repealing and reenacting, without amendments,
Article – Insurance
Section 15–851 and 15–10B–01(a)
Annotated Code of Maryland
(2017 Replacement Volume and 2023 Supplement)

BY repealing and reenacting, with amendments,
Article – Insurance
Section 15–854 and 15–10B–06
Annotated Code of Maryland
(2017 Replacement Volume and 2023 Supplement)
(As enacted by Chapters 364 and 365 of the Acts of the General Assembly of 2023)

BY adding to
Article – Insurance
Section 15–854.1
Annotated Code of Maryland
(2017 Replacement Volume and 2023 Supplement)

BY repealing and reenacting, with amendments,
Article – Insurance
Section 15–10A–01, 15–10A–02, 15–10A–04(c), 15–10A–06, 15–10A–08,
15–10B–01(b), 15–10B–02, 15–10B–05, 15–10B–07, and 15–10B–09.1
Annotated Code of Maryland
(2017 Replacement Volume and 2023 Supplement)
– 1 –

PAGE 2
Ch. 847 2024 LAWS OF MARYLAND

SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
That the Laws of Maryland read as follows:

Article – Health – General

19–108.5.

(A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS
INDICATED.

(2) “CARRIER” § 15–1301HAS THE MEANING STATED IN OF THE
INSURANCE ARTICLE.

(3) “HEALTH PROVIDER” §CARE HAS THE MEANING STATED IN
19–108.3 SUBTITLE.OF THIS

(B) (1) ON JULY 1, 2026,OR BEFORE A CARRIER SHALL ESTABLISH AND
THAT:MAINTAIN AN ONLINE PROCESS

(I) LINKS E–PRESCRIBINGDIRECTLY TO ALL SYSTEMS AND
NATIONAL COUNCILELECTRONIC HEALTH RECORD SYSTEMS THAT USE THE FOR
PRESCRIPTION DRUG PROGRAMS SCRIPT NATIONALSTANDARD AND THE
COUNCIL PRESCRIPTION DRUG PROGRAMS REAL TIME BENEFIT STANDARD;FOR

(II) CAN ACCEPT ELECTRONIC PRIOR AUTHORIZATION
PROVIDER;REQUESTS FROM A HEALTH CARE

(III) CAN APPROVE ELECTRONIC PRIOR AUTHORIZATION
REQUESTS:

1. FOR WHICH NO ADDITIONAL INFORMATION IS
REQUEST;NEEDED BY THE CARRIER TO PROCESS THE PRIOR AUTHORIZATION

2. FOR REQUIRED;WHICH NO CLINICAL REVIEW IS AND

3. THAT CARRIER’SMEET THE CRITERIA FOR
APPROVAL; AND

(IV) LINKS REAL–TIME OUT–OF–POCKETDIRECTLY TO PATIENT
COSTS, COPAYMENT, DEDUCTIBLE, COSTS,INCLUDING AND COINSURANCE AND
MORE AFFORDABLE MEDICATION ALTERNATIVES MADE AVAILABLE BY THE
CARRIER.

– 2 –

PAGE 3
WES MOORE, Governor Ch. 847

(2) A NOT:CARRIER MAY

(I) IMPOSE A FEE OR CHARGE ON A PERSON FOR ACCESSING
(1) SUBSECTION;THE ONLINE PROCESS REQUIRED UNDER PARAGRAPH OF THIS OR

(II) ACCESS, CONSENT,WITHOUT HEALTH CARE PROVIDER
HEALTH CARE PROVIDER DATA VIA THE ONLINE PROCESS OTHER THAN FOR THE
ENROLLEE.INSURED OR

(C) ON JULY 1, 2025, SHALL:OR BEFORE A CARRIER

(1) ON PROVIDER,REQUEST OF A HEALTH CARE PROVIDE CONTACT
THIRD–PARTYINFORMATION FOR EACH VENDOR OR OTHER ENTITY THAT THE
(B)CARRIER WILL USE TO MEET THE REQUIREMENTS OF SUBSECTION OF THIS
SECTION; AND

(2) POST THE CONTACT INFORMATION REQUIRED TO BE PROVIDED
(1) WEBSITE.UNDER ITEM OF THIS SUBSECTION ON ITS

(D) (1) ON JULY 1, 2026,OR BEFORE EACH HEALTH CARE PROVIDER
E–PRESCRIBINGSHALL ENSURE THAT EACH SYSTEM OR ELECTRONIC HEALTH
RECORD SYSTEM OWNED OR CONTRACTED FOR BY THE HEALTH CARE PROVIDER TO
MAINTAIN A HEALTH RECORD OF AN INSURED OR ENROLLEE HAS THE ABILITY TO
ACCESS, PRESCRIBING:AT THE POINT OF

(I) THE ELECTRONIC PRIOR AUTHORIZATION PROCESS
(B) SECTION;ESTABLISHED BY A CARRIER UNDER SUBSECTION OF THIS AND

(II) THE REAL–TIME OUT–OF–POCKETPATIENT COST
INFORMATION AND AVAILABLE MEDICATION ALTERNATIVES REQUIRED UNDER
(B) SECTION.SUBSECTION OF THIS

(2) THE COMMISSION SHALL ESTABLISH BY REGULATION A PROCESS
THROUGH WHICH A HEALTH CARE PROVIDER MAY REQUEST AND RECEIVE A WAIVER
SUBSECTION.OF COMPLIANCE FROM THE REQUIREMENTS OF THIS

(E) (1) ON JULY 1, 2026, CARRIER,OR BEFORE EACH OR A PHARMACY
CARRIER, SHALL:BENEFITS MANAGER ON BEHALF OF THE

(I) PROVIDE REAL–TIME PATIENT–SPECIFIC BENEFIT
INFORMATION TO INSUREDS AND ENROLLEES AND CONTRACTED HEALTH CARE
PROVIDERS, OUT–OF–POCKETINCLUDING ANY COSTS AND MORE AFFORDABLE
REQUIREMENTS;MEDICATION ALTERNATIVES OR PRIOR AUTHORIZATION AND

– 3 –

PAGE 4
Ch. 847 2024 LAWS OF MARYLAND

(II) ENSURE THAT THE INFORMATION PROVIDED UNDER ITEM
(I) ACCURATE.OF THIS PARAGRAPH IS

(2) EACH CARRIER, OR A PHARMACY BENEFITS MANAGER ON BEHALF
CARRIER,OF THE SHALL MAKE AVAILABLE THE INFORMATION REQUIRED TO BE
(1)PROVIDED UNDER PARAGRAPH OF THIS SUBSECTION TO THE HEALTH CARE
PROVIDER AT THE POINT OF PRESCRIBING IN AN ACCESSIBLE AND
FORMAT, PROVIDER’SUNDERSTANDABLE SUCH AS THROUGH THE HEALTH CARE
E–PRESCRIBING SYSTEM OR ELECTRONIC HEALTH RECORD SYSTEM THAT THE
CARRIER, MANAGER,PHARMACY BENEFITS OR DESIGNATED SUBCONTRACTOR HAS
NATIONAL COUNCIL PRESCRIPTION DRUGADOPTED THAT USES THE FOR
PROGRAMS SCRIPT NATIONAL COUNCIL PRESCRIPTIONSTANDARD AND THE FOR
DRUG PROGRAMS REAL TIME BENEFIT STANDARD FROM WHICH THE HEALTH
REQUEST.CARE PROVIDER MAKES THE

Article – Insurance

15–851.

(a) (1) This section applies to:

(i) insurers and nonprofit health service plans that provide coverage
for substance use disorder benefits or prescription drugs under individual, group, or
blanket health insurance policies or contracts that are issued or delivered in the State; and

(ii) health maintenance organizations that provide coverage for
substance use disorder benefits or prescription drugs under individual or group contracts
that are issued or delivered in the State.

(2) An insurer, a nonprofit health service plan, or a health maintenance
organization that provides coverage for substance use disorder benefits under the medical
benefit or for prescription drugs through a pharmacy benefits manager is subject to the
requirements of this section.

(b) An entity subject to this section may not apply a prior authorization
requirement for a prescription drug:

(1) when used for treatment of an opioid use disorder; and

(2) that contains methadone, buprenorphine, or naltrexone.

15–854.

(a) (1) This section applies to:

– 4 –

PAGE 5
WES MOORE, Governor Ch. 847

(i) insurers and nonprofit health service plans that provide coverage
for prescription drugs through a pharmacy benefit under individual, group, or blanket
health insurance policies or contracts that are issued or delivered in the State; and

(ii) health maintenance organizations that provide coverage for
prescription drugs through a pharmacy benefit under individual or group contracts that
are issued or delivered in the State.

(2) An insurer, a nonprofit health service plan, or a health maintenance
organization that provides coverage for prescription drugs through a pharmacy benefits
manager or that contracts with a private review agent under Subtitle 10B of this article is
subject to the requirements of this section.

(3) This section does not apply to a managed care organization as defined
in § 15–101 of the Health – General Article.

(b) (1) (i) If an entity subject to this section requires a prior authorization
for a prescription drug, the prior authorization request shall allow a health care provider
to indicate whether a prescription drug is to be used to treat a chronic condition.

(ii) If a health care provider indicates that the prescription drug is
to treat a chronic condition, an entity subject to this section may not request a
reauthorization for a repeat prescription for the prescription drug for 1 year or for the
standard course of treatment for the chronic condition being treated, whichever is less.

(2) For a prior authorization that is filed electronically, the entity shall
maintain a database that will prepopulate prior authorization requests with an insured’s
available insurance and demographic information.

[If(c) an entity subject to this section denies coverage for a prescription drug, the
entity shall provide a detailed written explanation for the denial of coverage, including
whether the denial was based on a requirement for prior authorization.

(d)] (1) On receipt of information documenting a prior authorization from the
insured or from the insured’s health care provider, an entity subject to this section shall
honor a prior authorization granted to an insured from a previous entity for at least the
[initial 30] 90 [ofdays an insured’s prescription drug benefit coverage underLESSER OF
entity]the health benefit plan of the new OR THE LENGTH OF THE COURSE OF
TREATMENT.

(2) During the time period described in paragraph (1) of this subsection, an
entity may perform its own review to grant a prior authorization for the prescription drug.

[(e)] (D) (1) An entity subject to this section shall honor a prior authorization
issued by the entity for a prescription drug AND MAY NOT REQUIRE A HEALTH CARE

– 5 –

PAGE 6
Ch. 847 2024 LAWS OF MARYLAND

PROVIDER TO SUBMIT A REQUEST FOR ANOTHER PRIOR AUTHORIZATION FOR THE
DRUG:PRESCRIPTION

(i) if the insured changes health benefit plans that are both covered
by the same entity and the prescription drug is a covered benefit under the current health
benefit plan; or

(ii) except as provided in paragraph (2) of this subsection, when the
dosage for the approved prescription drug changes and the change is consistent with federal
Food and Drug Administration labeled dosages.

[An] EXCEPT § 15–851 SUBTITLE,(2) AS PROVIDED IN OF THIS AN
[not honor]entity may be required to a prior authorization for a change in dosageREQUIRE
for an opioid under this subsection.

[(f)] (E) (1) If an entity under this section implements a new prior
authorization requirement for a prescription drug, the entity shall provide notice of the new
[30] 60requirement at least days before the implementation of a new prior authorization
requirement:

[(1)] (I) in writing to any insured who is prescribed the prescription drug;
and

[(2)] (II) either in writing or electronically to all contracted health care
providers.

(2) THE (1)NOTICE REQUIRED UNDER PARAGRAPH OF THIS
SUBSECTION SHALL INDICATE THAT THE INSURED MAY REMAIN ON THE
PRESCRIPTION DRUG AT THE TIME OF REAUTHORIZATION IN ACCORDANCE WITH
(G) SECTION.SUBSECTION OF THIS

[(g)] (F) (1) Except as provided in paragraph (2) of this subsection, an entity
subject to this section may not require more than one prior authorization if two or more
tablets of different dosage strengths of the same prescription drug are:

(i) prescribed at the same time as part of an insured’s treatment
plan; and

(ii) manufactured by the same manufacturer.

(2) This subsection does not prohibit an entity from requiring more than
one prior authorization if the prescription is for two or more tablets of different dosage
strengths of an opioid that is not an opioid partial agonist.

– 6 –

PAGE 7
WES MOORE, Governor Ch. 847

(G) (1) ~~THIS~~ ~~SUBSECTION~~ ~~DOES~~ ~~NOT~~ ~~APPLY~~ ~~WITH~~ ~~RESPECT~~ ~~TO~~ ~~A~~
~~REAUTHORIZATION~~ ~~OF~~ ~~A~~ ~~PRESCRIPTION~~ ~~DRUG~~ ~~REQUESTED~~ ~~BY~~ ~~A~~ ~~PROVIDER~~
~~ORGANIZATION,~~~~EMPLOYED~~ ~~BY~~ ~~A~~ ~~GROUP~~ ~~MODEL~~ ~~HEALTH~~ ~~MAINTENANCE~~ ~~AS~~ ~~DEFINED~~
~~§~~ ~~19–713.6~~ ~~HEALTH~~ ~~–~~ ~~GENERAL~~ ~~ARTICLE.~~~~IN~~ ~~OF~~ ~~THE~~

~~(2)~~ AN ENTITY SUBJECT TO THIS SECTION MAY NOT ISSUE AN
ADVERSE DECISION ON A REAUTHORIZATION FOR THE SAME PRESCRIPTION DRUG
OR REQUEST ADDITIONAL DOCUMENTATION FROM THE PRESCRIBER FOR THE
IF:REAUTHORIZATION REQUEST

(I) IS:THE PRESCRIPTION DRUG

1. (HUMAN) 21AN IMMUNE GLOBULIN AS DEFINED IN
C.F.R. § 640.100; OR

2. USED FOR THE TREATMENT OF A MENTAL DISORDER
DIAGNOSTIC STATISTICALLISTED IN THE MOST RECENT EDITION OF THE AND
MANUAL MENTAL DISORDERS AMERICAN PSYCHIATRICOF PUBLISHED BY THE
ASSOCIATION;

~~(I)~~ (II) THE ENTITY PREVIOUSLY APPROVED A PRIOR
INSURED;AUTHORIZATION FOR THE PRESCRIPTION DRUG FOR THE

~~(II)~~ (III) THE INSURED HAS BEEN TREATED WITH THE
PRESCRIPTION DRUG WITHOUT INTERRUPTION SINCE THE INITIAL APPROVAL OF
AUTHORIZATION;THE PRIOR AND

~~(III)~~ (IV) THAT,THE PRESCRIBER ATTESTS BASED ON THE
PRESCRIBER’S JUDGMENT,PROFESSIONAL THE PRESCRIPTION DRUG CONTINUES
INSURED’S CONDITION.TO BE NECESSARY TO EFFECTIVELY TREAT THE

~~(3)~~ (2) IF THE PRESCRIPTION DRUG THAT IS BEING REQUESTED HAS
BEEN REMOVED FROM THE FORMULARY OR HAS BEEN MOVED TO A HIGHER
DEDUCTIBLE, COPAYMENT, TIER,OR COINSURANCE THE ENTITY SHALL PROVIDE
INSURED’STHE INSURED AND HEALTH CARE PROVIDER THE INFORMATION
§ 15–831 SUBTITLE.REQUIRED UNDER OF THIS

15–854.1.

(A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS
INDICATED.

– 7 –

PAGE 8
Ch. 847 2024 LAWS OF MARYLAND

(2) “ACTIVE TREATMENT”COURSE OF MEANS A COURSE OF
TREATMENT FOR WHICH AN INSURED IS ACTIVELY SEEING A HEALTH CARE
TREATMENT.PROVIDER AND FOLLOWING THE COURSE OF

(3) “COURSE TREATMENT” THAT:OF MEANS TREATMENT

(I) IS PRESCRIBED TO TREAT OR ORDERED FOR THE
CONDITION;TREATMENT OF AN INSURED WITH A SPECIFIC

(II) IS OUTLINED AND AGREED TO BY THE INSURED AND THE
BEGINS;HEALTH CARE PROVIDER BEFORE THE TREATMENT AND

(III) PLAN.MAY BE PART OF A TREATMENT

(B) (1) THIS TO:SECTION APPLIES

(I) INSURERS AND NONPROFIT HEALTH SERVICE PLANS THAT
HOSPITAL, MEDICAL,PROVIDE OR SURGICAL BENEFITS TO INDIVIDUALS OR GROUPS
EXPENSE–INCURREDON AN BASIS UNDER HEALTH INSURANCE POLICIES OR
STATE;CONTRACTS THAT ARE ISSUED OR DELIVERED IN THE AND

(II) HEALTH MAINTENANCE ORGANIZATIONS THAT PROVIDE
HOSPITAL, MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GROUPS UNDER
STATE.CONTRACTS THAT ARE ISSUED OR DELIVERED IN THE

(2) AN INSURER, PLAN,A NONPROFIT HEALTH SERVICE OR A HEALTH
MAINTENANCE ORGANIZATION THAT CONTRACTS WITH A PRIVATE REVIEW AGENT
SUBTITLE 10BUNDER OF THIS TITLE IS SUBJECT TO THE REQUIREMENTS OF THIS
SECTION.

(3) AN INSURER, PLAN,A NONPROFIT HEALTH SERVICE OR A HEALTH
MAINTENANCE ORGANIZATION THAT CONTRACTS WITH A THIRD PARTY TO
DEVICES, APPLIANCES,DISPENSE MEDICAL MEDICAL OR MEDICAL GOODS FOR THE
TREATMENT OF A HUMAN DISEASE OR DYSFUNCTION IS SUBJECT TO THE
SECTION.REQUIREMENTS OF THIS

(C) (1) NOTWITHSTANDING § 15–854 OF THIS SUBTITLE AS IT APPLIES TO
DRUGS,COVERAGE FOR PRESCRIPTION AN ENTITY SUBJECT TO THIS SECTION
SHALL APPROVE A REQUEST FOR THE PRIOR AUTHORIZATION OF A COURSE OF
TREATMENT, CONDITIONS, SERVICES,INCLUDING FOR CHRONIC REHABILITATIVE
DISORDERS, CONDITIONS, IS:SUBSTANCE USE AND MENTAL HEALTH THAT

– 8 –

PAGE 9
WES MOORE, Governor Ch. 847

(I) FOR A PERIOD OF TIME THAT IS AS LONG AS NECESSARY TO
CARE;AVOID DISRUPTIONS IN AND

(II) DETERMINED IN ACCORDANCE WITH APPLICABLE
CRITERIA, INSURED’S HISTORY,COVERAGE THE MEDICAL AND THE HEALTH CARE
PROVIDER’S RECOMMENDATION.

(2) FOR ENROLLEES,NEW AN ENTITY SUBJECT TO THIS SECTION MAY
NOT DISRUPT OR REQUIRE REAUTHORIZATION FOR AN ACTIVE COURSE OF
90TREATMENT FOR COVERED SERVICES FOR AT LEAST DAYS AFTER THE DATE OF
ENROLLMENT.

15–10A–01.

(a) In this subtitle the following words have the meanings indicated.

(b) (1) “Adverse decision” means:

(i) a utilization review determination by a private review agent, a
carrier, or a health care provider acting on behalf of a carrier that:

1. a proposed or delivered health care service covered under
the member’s contract is or was not medically necessary, appropriate, or efficient; and

2. may result in noncoverage of the health care service; or

(ii) a denial by a carrier of a request by a member for an alternative
standard or a waiver of a standard to satisfy the requirements of a wellness program under
§ 15–509 of this title.

(2) “ADVERSE DECISION” INCLUDES A UTILIZATION REVIEW
DETERMINATION BASED ON A PRIOR AUTHORIZATION OR STEP THERAPY
REQUIREMENT.

[(2)] (3) “Adverse decision” does not include a decision concerning a
subscriber’s status as a member.

(c) “Carrier” means a person that offers a health benefit plan and is:

(1) an authorized insurer that provides health insurance in the State;

(2) a nonprofit health service plan;

(3) a health maintenance organization;

– 9 –

PAGE 10
Ch. 847 2024 LAWS OF MARYLAND

(4) a dental plan organization;

(5) a self–funded student health plan operated by an independent
institution of higher education, as defined in § 10–101 of the Education Article, that
provides health care to its students and their dependents; or

(6) except for a managed care organization as defined in Title 15, Subtitle
1 of the Health – General Article, any other person that provides health benefit plans
subject to regulation by the State.

(d) “Complaint” means a protest filed with the Commissioner involving an
adverse decision or grievance decision concerning the member.

(e) “Designee of the Commissioner” means any person to whom the Commissioner
has delegated the authority to review and decide complaints filed under this subtitle,
including an administrative law judge to whom the authority to conduct a hearing has been
delegated for recommended or final decision.

(f) “Grievance” means a protest filed by a member, a member’s representative, or
a health care provider on behalf of a member with a carrier through the carrier’s internal
grievance process regarding an adverse decision concerning the member.

(g) “Grievance decision” means a final determination by a carrier that arises from
a grievance filed with the carrier under its internal grievance process regarding an adverse
decision concerning a member.

(h) “Health Advocacy Unit” means the Health Education and Advocacy Unit in
the Division of Consumer Protection of the Office of the Attorney General established under
Title 13, Subtitle 4A of the Commercial Law Article.

(i) “Health benefit plan” has the meaning stated in § 2–112.2(a) of this article.

(j) “Health care provider” means:

(1) an individual who is licensed under the Health Occupations Article to
provide health care services in the ordinary course of business or practice of a profession
and is a treating provider of the member; or

(2) a hospital, as defined in § 19–301 of the Health – General Article.

(k) “Health care service” means a health or medical care procedure or service
rendered by a health care provider that:

(1) provides testing, diagnosis, or treatment of a human disease or
[or]dysfunction;

– 10 –

PAGE 11
WES MOORE, Governor Ch. 847

(2) dispenses drugs, medical devices, medical appliances, or medical goods
dysfunction;for the treatment of a human disease or OR

(3) CARE, SERVICE,PROVIDES ANY OTHER OR TREATMENT OF
INJURY, DEFECTS,DISEASE OR THE CORRECTION OF OR THE MAINTENANCE OF
WELL–BEING INDIVIDUALS.PHYSICAL OR MENTAL OF

(l) (1) “Member” means a person entitled to health care benefits under a
policy, plan, or certificate issued or delivered in the State by a carrier.

(2) “Member” includes:

(i) a subscriber; and

(ii) unless preempted by federal law, a Medicare recipient.

(3) “Member” does not include a Medicaid recipient.

(m) “Member’s representative” means an individual who has been authorized by
the member to file a grievance or a complaint on the member’s behalf.

(n) “Private review agent” has the meaning stated in § 15–10B–01 of this title.

15–10A–02.

(a) Each carrier shall establish an internal grievance process for its members.

(b) (1) An internal grievance process shall meet the same requirements
established under Subtitle 10B of this title.

(2) In addition to the requirements of Subtitle 10B of this title, an internal
grievance process established by a carrier under this section shall:

(i) include an expedited procedure for use in an emergency case for
purposes of rendering a grievance decision within 24 hours of the date a grievance is filed
with the carrier;

(ii) provide that a carrier render a final decision in writing on a
grievance within 30 working days after the date on which the grievance is filed unless:

1. the grievance involves an emergency case under item (i) of
this paragraph;

2. the member, the member’s representative, or a health care
provider filing a grievance on behalf of a member agrees in writing to an extension for a
period of no longer than 30 working days; or

– 11 –

PAGE 12
Ch. 847 2024 LAWS OF MARYLAND

3. the grievance involves a retrospective denial under item
(iv) of this paragraph;

(iii) allow a grievance to be filed on behalf of a member by a health
care provider or the member’s representative;

(iv) provide that a carrier render a final decision in writing on a
grievance within 45 working days after the date on which the grievance is filed when the
grievance involves a retrospective denial; and

(v) for a retrospective denial, allow a member, the member’s
representative, or a health care provider on behalf of a member to file a grievance for at
least 180 days after the member receives an adverse decision.

(3) For purposes of using the expedited procedure for an emergency case
that a carrier is required to include under paragraph (2)(i) of this subsection, the
[Commissioner shall define by regulation the standards required for a grievance to be
case]considered an emergency CARRIER SHALL INITIATE THE EXPEDITED PROCEDURE
MEMBER’SFOR AN EMERGENCY CASE IF THE MEMBER OR THE REPRESENTATIVE
REQUESTS THE EXPEDITED REVIEW OR THE HEALTH CARE PROVIDER OR THE
MEMBER’S THAT:MEMBER OR THE REPRESENTATIVE ATTESTS

(I) THE ADVERSE DECISION WAS RENDERED FOR HEALTH CARE
PROVIDED;SERVICES THAT ARE PROPOSED BUT HAVE NOT BEEN AND

(II) THE SERVICES ARE NECESSARY TO TREAT A CONDITION OR
THAT, ATTENTION, WOULD:ILLNESS WITHOUT IMMEDIATE MEDICAL

1. SERIOUSLY JEOPARDIZE THE LIFE OR HEALTH OF THE
MEMBER’S FUNCTIONS;MEMBER OR THE ABILITY TO REGAIN MAXIMUM

2. CAUSE THE MEMBER TO BE IN DANGER TO SELF OR
OTHERS; OR

3. CAUSE THE MEMBER TO CONTINUE USING
MANNER.INTOXICATING SUBSTANCES IN AN IMMINENTLY DANGEROUS

(c) Except as provided in subsection (d) of this section, the carrier’s internal
grievance process shall be exhausted prior to filing a complaint with the Commissioner
under this subtitle.

(d) (1) (i) A member, the member’s representative, or a health care
provider filing a complaint on behalf of a member may file a complaint with the

– 12 –

PAGE 13
WES MOORE, Governor Ch. 847

Commissioner without first filing a grievance with a carrier and receiving a final decision
on the grievance if:

1. the carrier waives the requirement that the carrier’s
internal grievance process be exhausted before filing a complaint with the Commissioner;

2. the carrier has failed to comply with any of the
requirements of the internal grievance process as described in this section; or

3. the member, the member’s representative, or the health
care provider provides sufficient information and supporting documentation in the
complaint that demonstrates a compelling reason to do so.

(ii) The Commissioner shall define by regulation the standards that
the Commissioner shall use to decide what demonstrates a compelling reason under
subparagraph (i) of this paragraph.

(2) Subject to subsections (b)(2)(ii) and (h) of this section, a member, a
member’s representative, or a health care provider may file a complaint with the
Commissioner if the member, the member’s representative, or the health care provider does
not receive a grievance decision from the carrier on or before the 30th working day on which
the grievance is filed.

(3) Whenever the Commissioner receives a complaint under paragraph (1)
or (2) of this subsection, the Commissioner shall notify the carrier that is the subject of the
complaint within 5 working days after the date the complaint is filed with the
Commissioner.

(e) Each carrier shall:

(1) file for review with the Commissioner and submit to the Health
Advocacy Unit a copy of its internal grievance process established under this subtitle; and

(2) file any revision to the internal grievance process with the
Commissioner and the Health Advocacy Unit at least 30 days before its intended use.

(1)(f) For nonemergency cases, when a carrier renders an adverse decision,
the carrier shall:

[(1)] (I) inform the member, the member’s representative, or the health
care provider acting on behalf of the member of the adverse decision:

[(i)] 1. orally by telephone; or

– 13 –

PAGE 14
Ch. 847 2024 LAWS OF MARYLAND

[(ii)] 2. with the affirmative consent of the member, the member’s
representative, or the health care provider acting on behalf of the member, by text,
facsimile, e–mail, an online portal, or other expedited means; and

[(2)] (II) send, within 5 working days after the adverse decision has been
made, a written notice to the member, the member’s representative, and a health care
provider acting on behalf of the member that:

[(i)] 1. states in detail in clear, understandable language the
specific factual bases for the carrier’s decision AND THE REASONING USED TO
DETERMINE THAT THE HEALTH CARE SERVICE IS NOT MEDICALLY NECESSARY AND
CARRIER’SDID NOT MEET THE CRITERIA AND STANDARDS USED IN CONDUCTING
REVIEW;THE UTILIZATION

[(ii)] 2. [references] REFERENCE,the specificPROVIDES
LANGUAGE, criteria and standards, includingOR REQUIREMENTS FROM THE ANY
use:interpretive guidelines, on which the decision was based, and may not solely

A. generalized terms such as “experimental procedure not
covered”, “cosmetic procedure not covered”, “service included under another procedure”, or
necessary”;“not medically OR

B. LANGUAGE DIRECTING THE MEMBER TO REVIEW THE
MEMBER’S DOCUMENTS;ADDITIONAL COVERAGE CRITERIA IN THE POLICY OR PLAN

[(iii)] 3. states the name, business address, and business telephone
number of:

[1.] A. IF THE CARRIER IS A HEALTH MAINTENANCE
ORGANIZATION, the medical director or associate medical director, as appropriate, who
[if organization];made the decision the carrier is a health maintenance or

[2.] B. IF THE CARRIER IS NOT A HEALTH
ORGANIZATION, the designated employee or representative of the carrierMAINTENANCE
[ifwho has responsibility for the carrier’s internal grievance process the carrier is not a
organization]health maintenance AND THE PHYSICIAN WHO IS REQUIRED TO MAKE
§ 15–10B–07(A) TITLE;ALL ADVERSE DECISIONS AS REQUIRED IN OF THIS

[(iv)] 4. gives written details of the carrier’s internal grievance
process and procedures under this subtitle; and

[(v)] 5. includes the following information:

– 14 –

PAGE 15
WES MOORE, Governor Ch. 847

[1.] A. that the member, the member’s representative, or a
health care provider on behalf of the member has a right to file a complaint with the
Commissioner within 4 months after receipt of a carrier’s grievance decision;

[2.] B. that a complaint may be filed without first filing a
grievance if the member, the member’s representative, or a health care provider filing a
grievance on behalf of the member can demonstrate a compelling reason to do so as
determined by the Commissioner;

[3.] C. the Commissioner’s address, telephone number,
and facsimile number;

[4.] D. a statement that the Health Advocacy Unit is
available to assist the member or the member’s representative in both mediating and filing
a grievance under the carrier’s internal grievance process; and

[5.] E. the address, telephone number, facsimile number,
and electronic mail address of the Health Advocacy Unit.

(2) THE BUSINESS TELEPHONE NUMBER INCLUDED IN THE NOTICE AS
(1)(II)3REQUIRED UNDER PARAGRAPH OF THIS SUBSECTION MUST BE A DEDICATED
NUMBER FOR ADVERSE DECISIONS AND MAY NOT BE THE GENERAL CUSTOMER CALL
CARRIER.NUMBER FOR THE

(g) If within 5 working days after a member, the member’s representative, or a
health care provider, who has filed a grievance on behalf of a member, files a grievance
with the carrier, and if the carrier does not have sufficient information to complete its
internal grievance process, the carrier shall:

(1) AFTER CONFIRMING THROUGH A COMPLETE REVIEW OF ANY
PROVIDER:INFORMATION ALREADY SUBMITTED BY THE HEALTH CARE

(I) notify the member, the member’s representative, or the health
care provider that it cannot proceed with reviewing the grievance unless additional
provided;information is

(II) INFORMATION,REQUEST THE SPECIFIC INCLUDING ANY
LAB OR DIAGNOSTIC TEST OR OTHER MEDICAL INFORMATION THAT MUST BE
PROCESS;SUBMITTED TO COMPLETE THE INTERNAL GRIEVANCE AND

(III) REFERENCE, LANGUAGE,PROVIDE THE SPECIFIC OR
REQUIREMENTS FROM THE CRITERIA AND STANDARDS USED BY THE CARRIER TO
INFORMATION; andSUPPORT THE NEED FOR THE ADDITIONAL

– 15 –

PAGE 16
Ch. 847 2024 LAWS OF MARYLAND

(2) assist the member, the member’s representative, or the health care
provider in gathering the necessary information without further delay.

(h) A carrier may extend the 30–day or 45–day period required for making a final
grievance decision under subsection (b)(2)(ii) of this section with the written consent of the
member, the member’s representative, or the health care provider who filed the grievance
on behalf of the member.

(i) (1) For nonemergency cases, when a carrier renders a grievance decision,
the carrier shall:

(i) document the grievance decision in writing after the carrier has
provided oral communication of the decision to the member, the member’s representative,
or the health care provider acting on behalf of the member; and

(ii) send, within 5 working days after the grievance decision has been
made, a written notice to the member, the member’s representative, and a health care
provider acting on behalf of the member that:

1. states in detail in clear, understandable language the
specific factual bases for the carrier’s decision AND THE REASONING USED TO
DETERMINE THAT THE HEALTH CARE SERVICE IS NOT MEDICALLY NECESSARY AND
CARRIER’SDID NOT MEET THE CRITERIA AND STANDARDS USED IN CONDUCTING
REVIEW;UTILIZATION

[references] REFERENCE,2. the specificPROVIDES
LANGUAGE, criteria and standards, includingOR REQUIREMENTS FROM THE ANY
interpretive guidelines CARRIER, on which the grievance decision wasUSED BY THE
based;

3. states the name, business address, and business telephone
number of:

A. IF THE CARRIER IS A HEALTH MAINTENANCE
ORGANIZATION, the medical director or associate medical director, as appropriate, who
made the grievance decision; or

B. IF THE CARRIER IS NOT A HEALTH MAINTENANCE
ORGANIZATION, the designated employee or representative of the carrier who has
[ifresponsibility for the carrier’s internal grievance process the carrier is not a health
organization] REPRESENTATIVE’Smaintenance AND THE DESIGNATED EMPLOYEE OR
SPECIALTY; andTITLE AND CLINICAL

4. includes the following information:

– 16 –

PAGE 17
WES MOORE, Governor Ch. 847

A. that the member or the member’s representative has a
right to file a complaint with the Commissioner within 4 months after receipt of a carrier’s
grievance decision;

B. the Commissioner’s address, telephone number, and
facsimile number;

C. a statement that the Health Advocacy Unit is available to
assist the member or the member’s representative in filing a complaint with the
Commissioner; and

D. the address, telephone number, facsimile number, and
electronic mail address of the Health Advocacy Unit.

(2) THE BUSINESS TELEPHONE NUMBER INCLUDED IN THE NOTICE AS
(1)(II)3REQUIRED UNDER PARAGRAPH OF THIS SUBSECTION MUST BE A DEDICATED
NUMBER FOR GRIEVANCE DECISIONS AND MAY NOT BE THE GENERAL CUSTOMER
CARRIER.CALL NUMBER FOR THE

[(2)] (3) [A] TO SUBSECTION,SATISFY THE REQUIREMENTS OF THIS
[a]carrier may not use solely in notice sent under paragraph (1) of thisA THE WRITTEN
subsection:

(I) generalized terms such as “experimental procedure not covered”,
“cosmetic procedure not covered”, “service included under another procedure”, or “not
[to subsection];medically necessary” satisfy the requirements of this OR

(II) LANGUAGE DIRECTING THE MEMBER TO REVIEW THE
MEMBER’S DOCUMENTS.ADDITIONAL COVERAGE CRITERIA IN THE POLICY OR PLAN

(j) (1) For an emergency case under subsection (b)(2)(i) of this section, within
1 day after a decision has been orally communicated to the member, the member’s
representative, or the health care provider, the carrier shall send notice in writing of any
adverse decision or grievance decision to:

(i) the member and the member’s representative, if any; and

(ii) if the grievance was filed on behalf of the member under
subsection (b)(2)(iii) of this section, the health care provider.

(2) A notice required to be sent under paragraph (1) of this subsection shall
include the following:

(i) for an adverse decision, the information required under
subsection (f) of this section; and

– 17 –

PAGE 18
Ch. 847 2024 LAWS OF MARYLAND

(ii) for a grievance decision, the information required under
subsection (i) of this section.

(k) (1) Each carrier shall include the information required by subsection
[(f)(2)(iii), (v)] (F)(1)(II)3, 4, 5(iv), and of this section in the policy, plan, certificate,AND
enrollment materials, or other evidence of coverage that the carrier provides to a member
at the time of the member’s initial coverage or renewal of coverage.

(2) Each carrier shall include as part of the information required by
paragraph (1) of this subsection a statement indicating that, when filing a complaint with
the Commissioner, the member or the member’s representative will be required to
authorize the release of any medical records of the member that may be required to be
reviewed for the purpose of reaching a decision on the complaint.

(l) (1) Nothing in this subtitle prohibits a carrier from delegating its internal
grievance process to a private review agent that has a certificate issued under Subtitle 10B
of this title and is acting on behalf of the carrier.

(2) If a carrier delegates its internal grievance process to a private review
agent, the carrier shall be:

(i) bound by the grievance decision made by the private review
agent acting on behalf of the carrier; and

(ii) responsible for a violation of any provision of this subtitle
regardless of the delegation made by the carrier under paragraph (1) of this subsection.

15–10A–04.

(c) (1) It is a violation of this subtitle for a carrier to fail to fulfill the carrier’s
obligations to provide or reimburse for health care services specified in the carrier’s policies
or contracts with members.

(2) If, in rendering an adverse decision or grievance decision, a carrier fails
to fulfill the carrier’s obligations to provide or reimburse for health care services specified
in the carrier’s policies or contracts with members, the Commissioner may:

(i) issue an administrative order that requires the carrier to:

1. cease inappropriate conduct or practices by the carrier or
any of the personnel employed or associated with the carrier;

2. fulfill the carrier’s contractual obligations;

3. provide a health care service or payment that has been
denied improperly; or

– 18 –

PAGE 19
WES MOORE, Governor Ch. 847

4. take appropriate steps to restore the carrier’s ability to
provide a health care service or payment that is provided under a contract; or

(ii) impose any penalty or fine or take any action as authorized:

1. for an insurer, nonprofit health service plan, or dental
plan organization, under this article; or

2. for a health maintenance organization, under the Health
– General Article or under this article.

(3) In addition to paragraph (1) of this subsection, it is a violation of this
subtitle, if the Commissioner, in consultation with an independent review organization,
medical expert, the Department, or other appropriate entity, determines that the criteria
and standards used by a health maintenance organization to conduct utilization review are
not[:

(i) objective;

(ii) clinically valid;

(iii) compatible with established principles of health care; or

(iv) flexible enough to allow deviations from norms when justified on
basis] ~~§~~ ~~15–10B–06~~ § 15–10B–05a case by case TITLE.IN ACCORDANCE WITH OF THIS

15–10A–06.

~~[a~~ ~~quarterly]~~(a) On basis, each carrier shall submit to the~~AN~~ ~~ANNUAL~~
Commissioner, on the form the Commissioner requires, a report that describes:

(1) the activities of the carrier under this subtitle, including:

(i) the outcome of each grievance filed with the carrier;

(ii) the number and outcomes of cases that were considered
emergency cases under § 15–10A–02(b)(2)(i) of this subtitle;

(iii) the time within which the carrier made a grievance decision on
each emergency case;

(iv) the time within which the carrier made a grievance decision on
all other cases that were not considered emergency cases;

– 19 –

PAGE 20
Ch. 847 2024 LAWS OF MARYLAND

(v) the number of grievances filed with the carrier that resulted from
an adverse decision involving length of stay for inpatient hospitalization as related to the
[and]medical procedure involved;

(vi) the number of adverse decisions issued by the carrier under §
subtitle, ~~USED,~~15–10A–02(f) of this ~~THE~~ ~~TYPE~~ ~~OF~~ ~~UTILIZATION~~ ~~REVIEW~~ ~~PROCESS~~ ~~IF~~
~~APPLICABLE,~~ WHETHER THE ADVERSE DECISION INVOLVED A PRIOR
PROTOCOL, and the type of service at issue in theAUTHORIZATION OR STEP THERAPY
[and]adverse decisions;

~~(VII)~~ ~~THE~~ ~~TIME~~ ~~WITHIN~~ ~~WHICH~~ ~~THE~~ ~~CARRIER~~ ~~MADE~~ ~~THE~~ ~~ADVERSE~~
~~DECISIONS;~~~~DECISIONS~~ ~~UNDER~~ ~~EACH~~ ~~TYPE~~ ~~OF~~ ~~SERVICE~~ ~~AT~~ ~~ISSUE~~ ~~IN~~ ~~THE~~ ~~ADVERSE~~

~~(VIII)~~ (VII) THE NUMBER OF ADVERSE DECISIONS OVERTURNED
§ 15–10B–06 TITLE;AFTER A RECONSIDERATION REQUEST UNDER OF THIS AND

~~(IX)~~ (VIII) THE NUMBER OF REQUESTS MADE AND GRANTED
§ 15–831(C)(1) (2) TITLE;UNDER AND OF THIS AND

(2) the number and outcome of all other cases that are not subject to
activities of the carrier under this subtitle that resulted from an adverse decision involving
the length of stay for inpatient hospitalization as related to the medical procedure involved.

(b) The Commissioner shall:

(1) compile an annual summary report based on the information provided:

(i) under subsection (a) of this section; and

(ii) by the Secretary under § 19–705.2(e) of the Health – General
[and]Article;

(2) §REPORT ANY VIOLATIONS OR ACTIONS TAKEN UNDER
15–10B–11 TITLE;OF THIS AND

[(2)] (3) provide copies of the summary report to the Governor and,
subject to § 2–1257 of the State Government Article, to the General Assembly.

15–10A–08.

(a) On or before November 1, 1999, and each November 1 thereafter, the Health
Advocacy Unit shall publish an annual summary report and provide copies of the report to
the Governor and, subject to § 2–1257 of the State Government Article, the General
Assembly.

– 20 –

PAGE 21
WES MOORE, Governor Ch. 847

(b) (1) The annual summary report required under subsection (a) of this
section shall be on the grievances and complaints filed with or referred to a carrier, the
Commissioner, the Health Advocacy Unit, or any other federal or State government agency
or unit under this subtitle during the previous fiscal year.

(2) In consultation with the Commissioner and any affected State
government agency or unit, the Health Advocacy Unit shall:

(i) evaluate the effectiveness of the internal grievance process and
complaint process available to members; and

(ii) include in the annual summary report the results of the
evaluation and any proposed changes that it considers necessaryTO THE LAW TO ENSURE
LAW.COMPLIANCE WITH THE PURPOSES OF THE

15–10B–01.

(a) In this subtitle the following words have the meanings indicated.

(b) (1) “Adverse decision” means a utilization review determination made by a
private review agent that a proposed or delivered health care service:

(i) is or was not medically necessary, appropriate, or efficient; and

(ii) may result in noncoverage of the health care service.

(2) “ADVERSE DECISION” INCLUDES A UTILIZATION REVIEW
DETERMINATION BASED ON A PRIOR AUTHORIZATION OR STEP THERAPY
REQUIREMENT.

[(2)] (3) “Adverse decision” does not include a decision concerning a
subscriber’s status as a member.

15–10B–02.

The purpose of this subtitle is to:

(1) promote the delivery of quality health care in a cost effective manner
SERVICES;THAT ENSURES TIMELY ACCESS TO HEALTH CARE

coordination, COMMUNICATION,(2) foster greater AND TRANSPARENCY
payors, PATIENTS,between and providers conducting utilization review activities;

(3) protect patients, business, and providers by ensuring that private
review agents are qualified to perform utilization review activities and to make informed
decisions on the appropriateness of medical care; and
– 21 –

PAGE 22
Ch. 847 2024 LAWS OF MARYLAND

(4) ensure that private review agents maintain the confidentiality of
medical records in accordance with applicable State and federal laws.

15–10B–05.

(a) In conjunction with the application, the private review agent shall submit
information that the Commissioner requires including:

(1) a utilization review plan that includes:

(i) the specific criteria and standards to be used in conducting
utilization review of proposed or delivered health care services;

(ii) those circumstances, if any, under which utilization review may
be delegated to a hospital utilization review program; and

(iii) if applicable, any provisions by which patients, physicians, ~~or~~OR
hospitals, may seek reconsideration;OR OTHER HEALTH CARE PROVIDERS

(2) the type and qualifications of the personnel either employed or under
contract to perform the utilization review;

(3) a copy of the private review agent’s internal grievance process if a
carrier delegates its internal grievance process to the private review agent in accordance
with § 15–10A–02(l) of this title;

(4) the procedures and policies to ensure that a representative of the
private review agent is reasonably accessible to patients and health care providers 7 days
a week, 24 hours a day in this State;

(5) if applicable, the procedures and policies to ensure that a representative
of the private review agent is accessible to health care providers to make all determinations
on whether to authorize or certify an emergency inpatient admission, or an admission for
residential crisis services as defined in § 15–840 of this title, for the treatment of a mental,
emotional, or substance abuse disorder within 2 hours after receipt of the information
necessary to make the determination;

(6) the policies and procedures to ensure that all applicable State and
federal laws to protect the confidentiality of individual medical records are followed;

(7) a copy of the materials designed to inform applicable patients and
providers of the requirements of the utilization review plan;

(8) a list of the third party payors for which the private review agent is
performing utilization review in this State;

– 22 –

PAGE 23
WES MOORE, Governor Ch. 847

(9) the policies and procedures to ensure that the private review agent has
a formal program for the orientation and training of the personnel either employed or under
contract to perform the utilization review;

(10) a list of the persons involved in establishing the specific criteria and
review, PERSON’Sstandards to be used in conducting utilization INCLUDING EACH
SPECIALTY, CATEGORY,BOARD CERTIFICATION OR PRACTICE LICENSURE AND
PERSON’S ORGANIZATION; andTITLE WITHIN THE

(11) certification by the private review agent that the criteria and standards
to be used in conducting utilization review are GENERALLY RECOGNIZED BY HEALTH
ARE:CARE PROVIDERS PRACTICING IN THE RELEVANT CLINICAL SPECIALTIES AND

(i) objective;

(ii) clinically valid;

[(iii) compatible with established principles of health care; and

(iv) flexible enough to allow deviations from norms when justified on
basis]a case by case

(III) PEER–REVIEWEDREFLECTED IN PUBLISHED SCIENTIFIC
LITERATURE;STUDIES AND MEDICAL

(IV) BY:DEVELOPED

1. A NONPROFIT HEALTH CARE PROVIDER
SOCIETY,PROFESSIONAL MEDICAL OR CLINICAL SPECIALTY INCLUDING THROUGH
GUIDELINES;THE USE OF PATIENT PLACEMENT CRITERIA AND CLINICAL PRACTICE
OR

2. FOR CRITERIA NOT WITHIN THE SCOPE OF A
NONPROFIT HEALTH CARE PROVIDER PROFESSIONAL MEDICAL OR CLINICAL
SOCIETY,SPECIALTY AN ORGANIZATION THAT WORKS DIRECTLY WITH HEALTH
CARE PROVIDERS IN THE SAME SPECIALTY FOR THE DESIGNATED CRITERIA WHO
ARE EMPLOYED OR ENGAGED WITHIN THE ORGANIZATION OR OUTSIDE THE
CRITERIA, ORGANIZATION:ORGANIZATION TO DEVELOP THE CLINICAL IF THE

A. DOES NOT RECEIVE DIRECT PAYMENTS BASED ON THE
REVIEW;OUTCOME OF THE UTILIZATION AND

– 23 –

PAGE 24
Ch. 847 2024 LAWS OF MARYLAND

B. DEMONSTRATES THAT ITS CLINICAL CRITERIA ARE
CONSISTENT WITH CRITERIA AND STANDARDS GENERALLY RECOGNIZED BY HEALTH
SPECIALTIES;CARE PROVIDERS PRACTICING IN THE RELEVANT CLINICAL

(V) AGENCIES;RECOMMENDED BY FEDERAL

(VI) FOOD DRUGAPPROVED BY THE FEDERAL AND
ADMINISTRATION LABELING;AS PART OF DRUG

(VII) TAKING INTO ACCOUNT THE NEEDS OF ATYPICAL PATIENT
DIAGNOSES,POPULATIONS AND INCLUDING THE UNIQUE NEEDS OF CHILDREN AND
ADOLESCENTS;

(VIII) SUFFICIENTLY FLEXIBLE TO ALLOW DEVIATIONS FROM
CASE–BY–CASE BASIS,NORMS WHEN JUSTIFIED ON A INCLUDING THE NEED TO USE
OFF–LABEL DRUG;AN PRESCRIPTION

(IX) SERVICES;ENSURING QUALITY OF CARE OF HEALTH CARE

(X) REVIEWED, EVALUATED, AND UPDATED AT LEAST
CHANGES;ANNUALLY AND AS NECESSARY TO REFLECT ANY AND

(XI) IN COMPLIANCE WITH ANY OTHER CRITERIA AND
TITLE,STANDARDS REQUIRED FOR COVERAGE UNDER THIS INCLUDING
§ 15–802(D)COMPLIANCE WITH OF THIS TITLE FOR THE TREATMENT OF SUBSTANCE
DISORDERS.USE

[On the] THE(b) the written request of any person or health care facility, private
[provide of]:review agent shall 1 copy

(1) CARRIER’S the specificPOST ON ITS WEBSITE OR THE WEBSITE
criteria and standards to be used in conducting utilization review of proposed or delivered
services and any subsequent revisions, modifications, or additions to the specific criteria
and standards to be used in conducting utilization review of proposed or delivered services
[to request];the person or health care facility making the AND

(2) PERSON,ON THE REQUEST OF A INCLUDING A HEALTH CARE
FACILITY, (1)PROVIDE A COPY OF THE INFORMATION SPECIFIED UNDER ITEM OF
REQUEST.THIS SUBSECTION TO THE PERSON MAKING THE

(c) The private review agent may charge a reasonable fee for a copy of theHARD
specific criteria and standards or any subsequent revisions, modifications, or additions to
the specific criteria to any person or health care facility requesting a copy under subsection
[(b)] (B)(2) of this section.

– 24 –

PAGE 25
WES MOORE, Governor Ch. 847

(d) A private review agent shall advise the Commissioner, in writing, of a change
in:

(1) ownership, medical director, or chief executive officer within 30 days of
the date of the change;

(2) the name, address, or telephone number of the private review agent
within 30 days of the date of the change; or

(3) the private review agent’s scope of responsibility under a contract.

15–10B–06.

[paragraph of](a) (1) Except as provided in (4) this subsection,OTHERWISE
a private review agent shall:

(i) make all initial determinations on whether to authorize or certify
SERVICE,a nonemergency course of treatment OR HEALTH CARE INCLUDING
ELECTRONICALLY, for a patient withinPHARMACEUTICAL SERVICES NOT SUBMITTED
2 working days after receipt of the information necessary to make the determination;

(ii) make all determinations on whether to authorize or certify an
extended stay in a health care facility or additional health care services within 1 working
[and]day after receipt of the information necessary to make the determination;

(III) MAKE ALL DETERMINATIONS TO AUTHORIZE OR CERTIFY A
REQUEST FOR ADDITIONAL VISITS OR DAYS OF CARE SUBMITTED AS PART OF AN
1EXISTING COURSE OF TREATMENT OR TREATMENT PLAN WITHIN WORKING DAY
DETERMINATION;AFTER RECEIPT OF THE INFORMATION NECESSARY TO MAKE THE
AND

[(iii)] (IV) promptly notify the health care provider of the
determination.

[If after] AFTER(2) within 3 calendar days receipt of the initial request
for health care services AND CONFIRMING THROUGH A COMPLETE REVIEW OF
PROVIDER, the privateINFORMATION ALREADY SUBMITTED BY THE HEALTH CARE IF
review agent does not have sufficientDETERMINES THAT THE PRIVATE REVIEW AGENT
PROMPTLY,information to make a determination, the private review agent shall BUT NOT
3 REQUEST, informLATER THAN CALENDAR DAYS AFTER RECEIPT OF THE INITIAL
SPECIFYING:the health care provider that additional information must be provided BY

– 25 –

PAGE 26
Ch. 847 2024 LAWS OF MARYLAND

(I) INFORMATION,THE INCLUDING ANY LAB OR DIAGNOSTIC
INFORMATION,TEST OR OTHER MEDICAL THAT MUST BE SUBMITTED TO COMPLETE
REQUEST;THE AND

(II) THE CRITERIA AND STANDARDS TO SUPPORT THE NEED FOR
INFORMATION.ADDITIONAL

[(3)] (B) If a private review agent requires prior authorization for an
emergency inpatient admission, or an admission for residential crisis services as defined in
§ 15–840 of this title, for the treatment of a mental, emotional, or substance abuse disorder,
the private review agent shall:

[(i)] (1) make all determinations on whether to authorize or certify
an inpatient admission, or an admission for residential crisis services as defined in §
15–840 of this title, within 2 hours after receipt of the information necessary to make the
[and]determination;

(2) NEEDED,IF ADDITIONAL INFORMATION IS PROMPTLY REQUEST
NEEDED,THE SPECIFIC INFORMATION INCLUDING ANY LAB OR DIAGNOSTIC TEST OR
INFORMATION;OTHER MEDICAL AND

[(ii)] (3) promptly notify the health care provider of the
determination.

[(4)] (C) (1) For a step therapy exception request submitted
electronically in accordance with a process established under § 15–142(f) of this title or a
prior authorization request submitted electronically for pharmaceutical services, a private
review agent shall make a determination:

(i) in real time if:

1. no additional information is needed by the private review
agent to process the request; and

2. the request meets the private review agent’s criteria for
approval; or

(ii) if a request is not approved under item (i) of thisIN REAL TIME
[business]paragraph, within 1 day after the private review agent receives all ofWORKING
the information necessary to make the determination.

(2) IF ADDITIONAL INFORMATION IS NEEDED TO MAKE A
DETERMINATION AFTER CONFIRMING THROUGH A COMPLETE REVIEW OF THE
PROVIDER,INFORMATION ALREADY SUBMITTED BY THE HEALTH CARE THE PRIVATE

– 26 –

PAGE 27
WES MOORE, Governor Ch. 847

PROMPTLY,REVIEW AGENT SHALL REQUEST THE INFORMATION BUT NOT LATER
3 REQUEST, SPECIFYING:THAN CALENDAR DAYS AFTER RECEIPT OF THE INITIAL BY

(I) INFORMATION,THE INCLUDING ANY LAB OR DIAGNOSTIC
INFORMATION,TEST OR OTHER MEDICAL THAT MUST BE SUBMITTED TO COMPLETE
REQUEST;THE AND

(II) THE CRITERIA AND STANDARDS TO SUPPORT THE NEED FOR
INFORMATION.THE ADDITIONAL

(D) (1) (I) ~~A~~ EXCEPT (G) (H)AS PROVIDED IN SUBSECTIONS AND OF
SECTION,THIS A PRIVATE REVIEW AGENT SHALL MAKE INITIAL DETERMINATIONS
ON WHETHER TO AUTHORIZE OR CERTIFY AN EMERGENCY COURSE OF TREATMENT
24OR HEALTH CARE SERVICE FOR A MEMBER WITHIN HOURS AFTER THE INITIAL
REQUEST AFTER RECEIPT OF THE INFORMATION NECESSARY TO MAKE THE
DETERMINATION.

(II) IF THE PRIVATE REVIEW AGENT DETERMINES THAT
ADDITIONAL INFORMATION IS NEEDED AFTER CONFIRMING THROUGH A COMPLETE
REVIEW OF THE INFORMATION ALREADY SUBMITTED BY THE HEALTH CARE
PROVIDER, SHALL:THE PRIVATE REVIEW AGENT

1. PROMPTLY REQUEST THE SPECIFIC INFORMATION
NEEDED, INCLUDING ANY LAB OR DIAGNOSTIC TEST OR OTHER MEDICAL
INFORMATION; AND

2. PROMPTLY, 2BUT NOT LATER THAN HOURS AFTER
INFORMATION,RECEIPT OF THE NOTIFY THE HEALTH CARE PROVIDER OF AN
AUTHORIZATION OR CERTIFICATION DETERMINATION WHEN MADE BY THE PRIVATE
AGENT.REVIEW

(2) A PRIVATE REVIEW AGENT SHALL INITIATE THE EXPEDITED
PATIENT’SPROCEDURE FOR AN EMERGENCY CASE IF THE PATIENT OR THE
REPRESENTATIVE REQUESTS OR IF THE HEALTH CARE PROVIDER ATTESTS THAT
THAT,THE SERVICES ARE NECESSARY TO TREAT A CONDITION OR ILLNESS WITHOUT
ATTENTION, WOULD:IMMEDIATE MEDICAL

(I) SERIOUSLY JEOPARDIZE THE LIFE OR HEALTH OF THE
MEMBER’S FUNCTIONS;MEMBER OR THE ABILITY TO REGAIN MAXIMUM

(II) OTHERS;CAUSE THE MEMBER TO BE IN DANGER TO SELF OR
OR

– 27 –

PAGE 28
Ch. 847 2024 LAWS OF MARYLAND

(III) CAUSE THE MEMBER TO CONTINUE USING INTOXICATING
MANNER.SUBSTANCES IN AN IMMINENTLY DANGEROUS

(E) IF A PRIVATE REVIEW AGENT FAILS TO MAKE A DETERMINATION WITHIN
SECTION,THE TIME LIMITS REQUIRED UNDER THIS THE REQUEST SHALL BE
APPROVED.DEEMED

[(b)] (F) (1) If an initial determination is made by a private review agent not
to authorize or certify a health care service and the health care provider believes the
[may]determination warrants an immediate reconsideration, a private review agent
provide the health care provider the opportunity to speak with the physician thatSHALL
rendered the determination, by telephone on an expedited basis, within a period of time not
to exceed 24 hours of the health care provider seeking the reconsideration.

(2) IF THE PHYSICIAN IS UNABLE TO IMMEDIATELY SPEAK WITH THE
RECONSIDERATION,HEALTH CARE PROVIDER SEEKING THE THE PHYSICIAN SHALL
PROVIDE THE HEALTH CARE PROVIDER WITH THE FOLLOWING CONTACT
INFORMATION FOR THE HEALTH CARE PROVIDER TO USE TO CONTACT THE
PHYSICIAN:

(I) A DIRECT TELEPHONE NUMBER THAT IS NOT THE GENERAL
NUMBER;CUSTOMER CALL OR

(II) E–MAILA MONITORED ADDRESS THAT IS DEDICATED TO
REVIEW.COMMUNICATION RELATED TO UTILIZATION

[(c)] (G) For emergency inpatient admissions, a private review agent may not
render an adverse decision solely because the hospital did not notify the private review
agent of the emergency admission within 24 hours or other prescribed period of time after
that admission if the patient’s medical condition prevented the hospital from determining:

(1) the patient’s insurance status; and

(2) if applicable, the private review agent’s emergency admission
notification requirements.

[(d)] (H) (1) Subject to paragraph (2) of this subsection, a private review
agent may not render an adverse decision as to an admission of a patient during the first
24 hours after admission when:

(i) the admission is based on a determination that the patient is in
imminent danger to self or others;

– 28 –

PAGE 29
WES MOORE, Governor Ch. 847

(ii) the determination has been made by the patient’s physician or
psychologist in conjunction with a member of the medical staff of the facility who has
privileges to make the admission; and

(iii) the hospital immediately notifies the private review agent of:

1. the admission of the patient; and

2. the reasons for the admission.

(2) A private review agent may not render an adverse decision as to an
admission of a patient to a hospital for up to 72 hours, as determined to be medically
necessary by the patient’s treating physician, when:

(i) the admission is an involuntary admission under §§ 10–615 and
10–617(a) of the Health – General Article; and

(ii) the hospital immediately notifies the private review agent of:

1. the admission of the patient; and

2. the reasons for the admission.

[(e)] (I) (1) A private review agent that requires a health care provider to
submit a treatment plan in order for the private review agent to conduct utilization review
of proposed or delivered services for the treatment of a mental illness, emotional disorder,
or a substance abuse disorder:

(i) shall accept:

1. the uniform treatment plan form adopted by the
Commissioner under § 15–10B–03(d) of this subtitle as a properly submitted treatment
plan form; or

2. if a service was provided in another state, a treatment plan
form mandated by the state in which the service was provided; and

(ii) may not impose any requirement to:

1. modify the uniform treatment plan form or its content; or

2. submit additional treatment plan forms.

(2) A uniform treatment plan form submitted under the provisions of this
subsection:

– 29 –

PAGE 30
Ch. 847 2024 LAWS OF MARYLAND

(i) shall be properly completed by the health care provider; and

(ii) may be submitted by electronic transfer.

15–10B–07.

(a) (1) Except as provided in paragraphs (2) and (3) of this subsection, all
adverse decisions shall be made by a physician, or a panel of other appropriateLICENSED
panel, is:health care service reviewers with at least one physician on the who

(I) board certified or eligible in the same specialty as the treatment
review;under AND

(II) KNOWLEDGEABLE ABOUT THE REQUESTED HEALTH CARE
EXPERIENCE.SERVICE OR TREATMENT THROUGH ACTUAL CLINICAL

(2) When the health care service under review is a mental health or
substance abuse service, the adverse decision shall be made by a physician, orLICENSED
a panel of other appropriate health care service reviewers with at least one LICENSED
physician, selected by the private review agent who:

(i) is board certified or eligible in the same specialty as the
treatment under review; or

(ii) is actively practicing or has demonstrated expertise in the
substance abuse or mental health service or treatment under review.

(3) When the health care service under review is a dental service, the
adverse decision shall be made by a licensed dentist, or a panel of other appropriate health
care service reviewers with at least one licensed dentist on the panel WHO IS
KNOWLEDGEABLE ABOUT THE REQUESTED HEALTH CARE SERVICE OR TREATMENT
EXPERIENCE.THROUGH ACTUAL CLINICAL

(b) All adverse decisions shall be made by a physician or a panel of other
appropriate health care service reviewers who are not compensated by the private review
agent in a manner that violates § 19–705.1 of the Health – General Article or that deters
the delivery of medically appropriate care.

(c) Except as provided in subsection (d) of this section, if a course of treatment
has been preauthorized or approved for a patient, a private review agent may not
retrospectively render an adverse decision regarding the preauthorized or approved
services delivered to that patient.

(d) A private review agent may retrospectively render an adverse decision
regarding preauthorized or approved services delivered to a patient if:

– 30 –

PAGE 31
WES MOORE, Governor Ch. 847

(1) the information submitted to the private review agent regarding the
services to be delivered to the patient was fraudulent or intentionally misrepresentative;

(2) critical information requested by the private review agent regarding
services to be delivered to the patient was omitted such that the private review agent’s
determination would have been different had the agent known the critical information; or

(3) the planned course of treatment for the patient that was approved by
the private review agent was not substantially followed by the provider.

(e) If a course of treatment has been preauthorized or approved for a patient, a
private review agent may not revise or modify the specific criteria or standards used for the
utilization review to make an adverse decision regarding the services delivered to that
patient.

15–10B–09.1.

A grievance decision shall be made based on the professional judgment of:

(1) (i) a physician who is board certified or eligible in theLICENSED
same specialty as the treatment under review AND KNOWLEDGEABLE ABOUT THE
REQUESTED HEALTH CARE SERVICE OR TREATMENT THROUGH ACTUAL CLINICAL
EXPERIENCE; or

(ii) a panel of other appropriate health care service reviewers with
at least one physician on the panel who is board certified or eligible in the sameLICENSED
specialty as the treatment under review AND KNOWLEDGEABLE ABOUT THE
REQUESTED HEALTH CARE SERVICE OR TREATMENT THROUGH ACTUAL CLINICAL
EXPERIENCE;

(2) when the grievance decision involves a dental service, a licensed
dentist, or a panel of appropriate health care service reviewers with at least one dentist on
the panel who is a licensed dentist, who shall consult with a dentist who is board certified
or eligible in the same specialty as the service under review AND KNOWLEDGEABLE
ABOUT THE REQUESTED HEALTH CARE SERVICE OR TREATMENT THROUGH ACTUAL
EXPERIENCE; orCLINICAL

(3) when the grievance decision involves a mental health or substance
abuse service:

(i) a licensed physician who:

1. is board certified or eligible in the same specialty as the
treatment under review; or

– 31 –

PAGE 32
Ch. 847 2024 LAWS OF MARYLAND

2. is actively practicing or has demonstrated expertise in the
substance abuse or mental health service or treatment under review; or

(ii) a panel of other appropriate health care service reviewers with
at least one physician, selected by the private review agent who:LICENSED

1. is board certified or eligible in the same specialty as the
treatment under review; or

2. is actively practicing or has demonstrated expertise in the
substance abuse or mental health service or treatment under review.

SECTION 2. AND BE IT FURTHER ENACTED, That:

(a) The Maryland Health Care Commission and the Maryland Insurance
Administration, in consultation with health care practitioners and payors of health care
services, jointly shall conduct a study on the development of standards for the
implementation of payor programs to modify prior authorization requirements for
prescription drugs, medical care, and other health care services based on health care
practitioner–specific criteria.

(b) The study conducted under subsection (a) of this section shall include, through
an examination of literature review and legislatively or voluntarily established programs
that have been implemented or are being considered in other states, an analysis of:

(1) adjustments to payor prior authorization requirements based on a
health care practitioner’s:

(i) prior approval rates;

(ii) ordering and prescribing patterns; and

(iii) participation in a payor’s two–sided incentive arrangement or a
capitation program; and

(2) any other information or metrics necessary to implement the payor
programs.

(c) On or before December 1, 2024, the Maryland Health Care Commission and
the Maryland Insurance Administration jointly shall submit a report to the General
Assembly, in accordance with § 2–1257 of the State Government Article, with the findings
and recommendations from the study, including recommendations for legislative initiatives
necessary for the establishment of payor programs modifying prior authorization
requirements based on health care practitioner–specific criteria.

SECTION 3. AND BE IT FURTHER ENACTED, That:

– 32 –

PAGE 33
WES MOORE, Governor Ch. 847

(a) The Maryland Health Care Commission ~~and~~ ~~the~~ ~~Maryland~~ ~~Insurance~~
~~Administration~~ ~~jointly~~ ~~shall~~ ~~establish~~ ~~a~~ ~~workgroup~~ ~~to,~~ in consultation with the Maryland
Insurance Administration, shall:

(1) ~~assess~~ monitor the progress toward implementing the requirements in
§ 19–108.5 of the Health – General Article, as enacted by Section 1 of this Act, including
monitoring any federal or State developments relating to the requirements; and

(2) review issues or recommendations from other states that are
implementing a real–time benefit requirement, including establishing a link at the point of
prescribing for any available coupons.

(b) On or before December 1, 2025, the Maryland Health Care Commission ~~and~~
~~the~~ ~~Maryland~~ ~~Insurance~~ ~~Administration~~ ~~jointly~~ ~~shall~~ ~~submit~~ ~~a~~ ~~report~~ ~~to~~ shall inform the
General Assembly, in accordance with § 2–1257 of the State Government Article, ~~with~~ of
any findings and recommendations ~~from~~ ~~the~~ ~~workgroup~~ relating to the implementation of
§ 19–108.5 of the Health – General Article, as enacted by Section 1 of this Act.

SECTION 4. AND BE IT FURTHER ENACTED, That Section 1 of this Act shall take
effect January 1, 2025.

SECTION 5. AND BE IT FURTHER ENACTED, That, except as provided in Section
4 of this Act, this Act shall take effect July 1, 2024.

Approved by the Governor, May 16, 2024.

– 33 –